Difference between revisions of "Debrisoquine"
From Self-sufficiency
m (Stub sorting and placement of stub template(s): antihypertensive-stub) |
m (1 revision) |
(No difference)
| |
Latest revision as of 09:58, 20 September 2010
| Debrisoquine[1] | |
|---|---|
| File:Debrisoquine.svg | |
| 1,2,3,4-tetrahydroisoquinoline-2-carboximidamide | |
| style="background: #F8EABA; text-align: center;" colspan="2" | Identifiers | |
| CAS number | 1131-64-2 
|
| PubChem | 2966 |
| ChemSpider | 2860 |
| MeSH | Debrisoquine |
| SMILES | Script error: No such module "collapsible list". |
| InChI | Script error: No such module "collapsible list". |
| InChI key | JWPGJSVJDAJRLW-UHFFFAOYAE |
| style="background: #F8EABA; text-align: center;" colspan="2" | Properties | |
| Molecular formula | C10H13N3 |
| Molar mass | 175.23032 |
 (what is this?) (verify)Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
| Infobox references | |
Debrisoquine is a derivative of guanidine. It is an antihypertensive drug similar to guanethidine. Debrisoquine is frequently used for phenotyping the CYP2D6 enzyme, a drug metabolizing enzyme.[2]
See also
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40px | This antihypertensive-related article is a stub. You can help ssf by expanding it. |
- ↑ Debrisoquine - Compound Summary, PubChem.
- ↑ [1] Appropriate Phenotyping Procedures for Drug Metabolizing Enzymes and Transporters in Humans and Their Simultaneous Use in the "Cocktail" Approach
